Literature DB >> 16426253

Mast cell activation and leukotriene secretion in wheezing infants. Relation to respiratory syncytial virus and outcome.

Knut Øymar1, Thomas Halvorsen, Lage Aksnes.   

Abstract

The persistence of wheezing after early wheezing episodes in infancy may be related to the virus involved and to the type of inflammation during the initial wheezing. The role of mast cell activation and leukotriene secretion in wheezing, and the relation to outcome, is not known. Our objective was to study markers of mast cell activation and leukotriene secretion from wheezing infants, and the relation to respiratory syncytial virus (RSV) infection and persistent wheezing. Urinary 9alpha,11beta-PGF(2), a marker of mast cell activation, and urinary leukotriene E4 were measured in 106 infants hospitalized for wheezing during their first year of life. Results were related to the presence of RSV infection and the persistence of wheezing at follow-up 20 months later. Levels of 9alpha,11beta-PGF(2) were higher in infants positive for RSV than in those with RSV negative wheezing, but both groups had higher levels than controls. Leukotriene E4 levels were higher in wheezing infants than in controls. Urinary 9alpha,11beta-PGF(2) levels were higher in infants with transient compared with persistent wheezing. We found a positive correlation between 9alpha,11beta-PGF(2) and leukotriene E4, strongest in infants with RSV negative disease and in infants with persistent wheezing. The results suggest that mast cells play an important role in infant wheezing, and may be a major source of leukotriene secretion in these infants. Mast cell activation and leukotriene secretion were not associated with persistent wheezing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426253     DOI: 10.1111/j.1399-3038.2005.00345.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  7 in total

1.  Tuft cell-produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation.

Authors:  Saltanat Ualiyeva; Evan Lemire; Evelyn C Aviles; Caitlin Wong; Amelia A Boyd; Juying Lai; Tao Liu; Ichiro Matsumoto; Nora A Barrett; Joshua A Boyce; Adam L Haber; Lora G Bankova
Journal:  Sci Immunol       Date:  2021-12-24

2.  Airway brush cells generate cysteinyl leukotrienes through the ATP sensor P2Y2.

Authors:  Saltanat Ualiyeva; Nils Hallen; Yoshihide Kanaoka; Carola Ledderose; Ichiro Matsumoto; Wolfgang G Junger; Nora A Barrett; Lora G Bankova
Journal:  Sci Immunol       Date:  2020-01-17

Review 3.  Mast Cell Responses to Viruses and Pathogen Products.

Authors:  Jean S Marshall; Liliana Portales-Cervantes; Edwin Leong
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

Review 4.  Mast Cells and Natural Killer Cells-A Potentially Critical Interaction.

Authors:  Liliana Portales-Cervantes; Bassel Dawod; Jean S Marshall
Journal:  Viruses       Date:  2019-06-04       Impact factor: 5.048

5.  Exhaled nitric oxide is related to atopy, but not asthma in adolescents with bronchiolitis in infancy.

Authors:  Ingvild Bruun Mikalsen; Thomas Halvorsen; Knut Øymar
Journal:  BMC Pulm Med       Date:  2013-11-17       Impact factor: 3.317

Review 6.  Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting.

Authors:  Amanda J Driscoll; S Hasan Arshad; Louis Bont; Steven M Brunwasser; Thomas Cherian; Janet A Englund; Deshayne B Fell; Laura L Hammitt; Tina V Hartert; Bruce L Innis; Ruth A Karron; Gayle E Langley; E Kim Mulholland; Patrick K Munywoki; Harish Nair; Justin R Ortiz; David A Savitz; Nienke M Scheltema; Eric A F Simões; Peter G Smith; Fred Were; Heather J Zar; Daniel R Feikin
Journal:  Vaccine       Date:  2020-01-20       Impact factor: 3.641

Review 7.  Mast Cell Modulation of B Cell Responses: An Under-Appreciated Partnership in Host Defence.

Authors:  Alejandro M Palma; Mark R Hanes; Jean S Marshall
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.